Literature DB >> 15635662

Defining the ends of Parkin exon 4 deletions in two different families with Parkinson's disease.

Jordi Clarimon1, Janel Johnson, Okan Dogu, Wagner Horta, Naheed Khan, Andrew J Lees, John Hardy, Andrew Singleton.   

Abstract

Autosomal recessive juvenile parkinsonism (AR-JP, PARK2) is characterized by an early onset parkinsonism, often presenting with dystonia as an early feature. Mutations in Parkin are a relatively common cause of AR-JP and are estimated to be present in approximately 30% of familial young onset Parkinson disease (PD) [Abbas et al. (1999); Hum Mol Genet 8:567-574]. These mutations include exon rearrangements (deletions and duplications), point mutations, and small deletions. Similar genomic mutations have been described in unrelated patients, thereby indicating independent mutational events or ancient founder effects. We have identified homozygous deletion mutations of exon 4 in Parkin in two unrelated families, one from Brazil and the other from Turkey [Dogu et al. (2004); Mov Dis 9:812-816; Khan et al., Mov Dis, in press]. We have performed molecular analysis of the deletion breakpoints and this data indicates these mutations originated independently. We present here data demonstrating that the mutation responsible for disease in the Brazilian kindred consists of two separate deletions (1,069 and 1,750 bp) surrounding and including exon 4. The deletion removing parkin exon 4 identified in the Turkish family extended 156,203 bp. In addition to demonstrating that disease in these families is not caused by a single founder mutation, these data show that there is no common fragile site between these mutational events. (c) 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15635662     DOI: 10.1002/ajmg.b.30119

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  11 in total

1.  Mechanisms of genomic instabilities underlying two common fragile-site-associated loci, PARK2 and DMD, in germ cell and cancer cell lines.

Authors:  Jun Mitsui; Yuji Takahashi; Jun Goto; Hiroyuki Tomiyama; Shunpei Ishikawa; Hiroyo Yoshino; Narihiro Minami; David I Smith; Suzanne Lesage; Hiroyuki Aburatani; Ichizo Nishino; Alexis Brice; Nobutaka Hattori; Shoji Tsuji
Journal:  Am J Hum Genet       Date:  2010-07-09       Impact factor: 11.025

Review 2.  Twenty years since the discovery of the parkin gene.

Authors:  Nobutaka Hattori; Yoshikuni Mizuno
Journal:  J Neural Transm (Vienna)       Date:  2017-06-15       Impact factor: 3.575

Review 3.  Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update.

Authors:  Karen Nuytemans; Jessie Theuns; Marc Cruts; Christine Van Broeckhoven
Journal:  Hum Mutat       Date:  2010-07       Impact factor: 4.878

4.  Breakpoint mapping of 13 large parkin deletions/duplications reveals an exon 4 deletion and an exon 7 duplication as founder mutations.

Authors:  Peter Elfferich; Marja C Verleun-Mooijman; J Anneke Maat-Kievit; Bart P C van de Warrenburg; Wilson F Abdo; Sylvia A Eshuis; Klaus L Leenders; Ad Hovestadt; Jan C M Zijlmans; Jan-Pieter M Stroy; John C van Swieten; Agnita J W Boon; Klaartje van Engelen; Corien C Verschuuren-Bemelmans; Saskia A J Lesnik-Oberstein; Cristina Tassorelli; Leonardo Lopiano; Vincenzo Bonifati; Dennis Dooijes; Rick van Minkelen
Journal:  Neurogenetics       Date:  2011-10-13       Impact factor: 2.660

5.  Parkinson's Disease in Saudi Patients: A Genetic Study.

Authors:  Bashayer R Al-Mubarak; Saeed A Bohlega; Thamer S Alkhairallah; Amna I Magrashi; Maha I AlTurki; Dania S Khalil; Basma S AlAbdulaziz; Hussam Abou Al-Shaar; Abeer E Mustafa; Eman A Alyemni; Bashayer A Alsaffar; Asma I Tahir; Nada A Al Tassan
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

6.  Genomic instability in the PARK2 locus is associated with Parkinson's disease.

Authors:  Wojciech Ambroziak; Dariusz Koziorowski; Kinga Duszyc; Paulina Górka-Skoczylas; Anna Potulska-Chromik; Jarosław Sławek; Dorota Hoffman-Zacharska
Journal:  J Appl Genet       Date:  2015-04-02       Impact factor: 3.240

7.  Correlations between long inverted repeat (LIR) features, deletion size and distance from breakpoint in human gross gene deletions.

Authors:  Nevim Aygun
Journal:  Sci Rep       Date:  2015-02-06       Impact factor: 4.379

8.  Significance of the parkin and PINK1 gene in Jordanian families with incidences of young-onset and juvenile parkinsonism.

Authors:  Ronny Myhre; Stina Steinkjer; Alice Stormyr; Gina L Nilsen; Hiba Abu Zayyad; Khalid Horany; Mohamad K Nusier; Helge Klungland
Journal:  BMC Neurol       Date:  2008-12-16       Impact factor: 2.474

9.  Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson's Disease.

Authors:  Anna Oczkowska; Wojciech Kozubski; Margarita Lianeri; Jolanta Dorszewska
Journal:  Curr Genomics       Date:  2013-12       Impact factor: 2.236

10.  Genomic mechanisms underlying PARK2 large deletions identified in a cohort of patients with PD.

Authors:  Sara Morais; Rita Bastos-Ferreira; Jorge Sequeiros; Isabel Alonso
Journal:  Neurol Genet       Date:  2016-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.